Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine

NCT05760976 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05760976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2023
Completion date
August 31, 2023
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fasciculation, succinylcholine